IntellxxDNA

Diagnostic

Empowering clinicians with genomics-based insights to improve patient outcomes and personalize care.

Services
  • Clinical Decision Support Tool
  • Health Focused Genomic Reports
Location Austin, Texas
About

IntellxxDNA

In an era where precision is paramount, IntellxxDNA is revolutionizing the way physicians approach healthcare decisions. Unlike traditional genomics tools that focus solely on pharmacogenomics, cancer genomics, or rare diseases, IntellxxDNA provides a comprehensive solution for managing multifactorial chronic conditions such as heart disease, diabetes, cognitive decline, mental health issues, and autism, among others. By enabling physicians to identify and address the root causes of diseases, IntellxxDNA not only improves prevention and treatment but also reduces the cost of healthcare.

What sets IntellxxDNA apart is its ability to make genomics truly actionable. IntellxxDNA empowers physicians to implement personalized, precise treatment plans by reporting on gene variants with well-understood functions and pairing them with targeted potential interventions, including diet, lifestyle modifications, supplements and medications. This innovative approach is already being utilized by top physicians across the US to enhance patient outcomes and satisfaction and is being utilized in three IRB-approved trials focused on improving outcomes in cognitive decline and children with complex illness.

Unlock exclusive discounts and offers from IntellxxDNA and other trusted partners with an SSRP Pro Membership.
What People Say

Testimonials

I wanted to add my two cents worth in support of IntellxxDNA and Dr Sharon Hausman-Cohen MD, et al, as a Trusted Partner with SSRP. I have used different genetics companies in my practices since 2010, starting with Kendal Stewart, MD, working the actionable SNP’s to improve health in my patients care. Over the years I never really found a platform that provided relevant clinical guidance with all of the evidence backed research at your fingertips prior to engaging with Dr Hausman-Cohen and IntellxxDNA. I was so impressed I recommend this company to Dr Seeds as one of the missing pieces in the Cellular Medicine puzzle. Dr Seeds got back to me and expressed is thanks for introducing Dr Hausman-Cohen. He said that she was the first doctor that could answer all his questions and provide a workable clinical platform to make the complex useful and improve the clinical success that SSRP Members are looking for. I have attended their monthly case studies, worked with their trainers on my complex patients and can say their support is excellent, the guidance is clinically valuable and adding IntellxxDNA to the Trusted Partners will be a valuable benefit for our Membership.

Kenton Crowley, Pharm.D., ABAAHP, FAARFM, CEO, President Palliative Care Consultants, LLC.; Crowley Consultants, Inc.
Network with our partners

Upcoming Events

View Upcoming Events
EVENT
Grand Rounds
December 4 - 5, 2026

Grand Rounds

Coming Soon
RESOURCES

Join us in breaking down the latest research live.

VIEW ALL
VIDEO
Cellular Medicine Mondays
Nov 16, 2026
Ep. 114 Anti-Aging Mini Mastermind Part 4
Preview only
Journal Club – Episode 114

In Part 4 of the Anti-Aging Mini Mastermind, Dr. Seeds explores how NAD synthesis, mitochondrial function, and cellular signaling influence immune function, inflammation, and aging through the lens of cellular medicine.

Preview Only — Become a member for full access
SSRP Institute Nov 12, 2026
FDA Requires New Safety Warnings for GLP-1 Receptor Agonists Due to Potential Vision Risk
BREAKING NEWS [NOVEMBER 12, 2026] – On November 9, the U.S. Food and Drug Administration (FDA) announced new safety labeling requirements for glucagon-like peptide-1 receptor agonists (GLP-1 RAs), citing a potential increased risk of nonarteritic anterior ischemic optic neuropathy (NAION), a rare but serious condition that can cause sudden, painless vision loss, sometimes permanently. The […]
READ NEWS
PODCAST
Redox Revolution
Nov 10, 2026
Ep.85 – An Update On The Research Related to GLP-1 Peptides – The Widening Benefits
Ep.85 – An Update On The Research Related to GLP-1 Peptides – The Widening Benefits

Dr. Seeds discusses recent research that shows how GLP-1 peptides are central regulators of cellular physiology, positively affecting cardiovascular, renal, neurologic, hepatic, musculoskeletal, and overall health.

Peptides & Protocols
Promoitalia Nov 5, 2026
SSRP Institute Welcomes Promoitalia as New Trusted Partner
PARTNER ANNOUNCEMENT WILLOUGHBY, Ohio, [November 5, 2026] — The SSRP Institute announces that Promoitalia has joined its Trusted Partner Network following nomination and completion of the SSRP’s internal review process. Promoitalia is an Italian aesthetic medicine company that develops professional technologies, methodologies, and consumable products for regenerative aesthetics and skin health. Its work combines professional […]
READ NEWS
SSRP Institute Oct 29, 2026
Dr. Seeds and Medivive Announce the Redox Smart Pen: A Novel Technology for Precise Peptide Administration
BREAKING NEWS WILLOUGHBY, Ohio [October 29, 2026] — Dr. Seeds and Medivive announce the launch of the Redox Smart Pen, an innovative pre-filled autoinjector peptide delivery system designed to improve precision and consistency in physician-directed peptide protocols. Importantly, the Redox Smart Pen was developed through a proprietary methodology focused on uniform potency, accuracy of administration, […]
READ NEWS
PharmaNutra Oct 22, 2026
SSRP Institute Welcomes PharmaNutra as New Trusted Partner
PARTNER ANNOUNCEMENT WILLOUGHBY, Ohio, [October 22, 2026] — The SSRP Institute announces that PharmaNutra has joined its Trusted Partner Network following nomination and completion of the SSRP’s internal review process. Founded in Italy in 2003, PharmaNutra is a pharmaceutical and nutraceutical company focused on the research, development, and production of nutritional supplements and medical devices. […]
READ NEWS
ARTICLE
William Seeds, MD
Oct 8, 2026
EP2, Tissue-Resident Macrophages, and a New Mechanism of Organ Aging
William Seeds, MD Oct 8, 2026
EP2, Tissue-Resident Macrophages, and a New Mechanism of Organ Aging
Revisiting a Journal Club Article, “Restored clearance of senescent neutrophils by tissue-resident macrophages limits organ aging.” Science. 2026  Why This Paper Matters Most of the senescence conversation over the past decade has centered on a familiar cast: senescent fibroblasts, endothelial cells, adipocytes, and the drugs designed to clear them. This paper, which I discuss in […]
READ ARTICLE
Healthgevity Oct 2, 2026
Healthgevity Introduces hydraCELL+™, Featuring Formulation IP Developed by the Seeds Foundation for Cellular Research
BREAKING NEWS INTERLAKEN, N.J., [October 2, 2026] — Healthgevity, a practitioner-focused precision longevity nutrition company, announced the launch of hydraCELL+™, a cellular hydration and muscle-support formula built on proprietary formulation IP developed through the Seeds Foundation for Cellular Research and licensed to Healthgevity. The formula reflects the cellular medicine approach advanced by William Seeds, MD, and […]
READ NEWS
ARTICLE
William Seeds, MD
Sep 23, 2026
The Future of Regenerative Medicine May Begin with a Hair Follicle
William Seeds, MD Sep 23, 2026
The Future of Regenerative Medicine May Begin with a Hair Follicle
Why a Plucked Hair Follicle May Matter to the Future of Regenerative Medicine In this article, I return to a study that I discussed in a July Journal Club post. The study, published in Cells in 2024, investigated whether cells obtained from plucked, cryopreserved human hair follicles could be reprogrammed into induced pluripotent stem cells […]
READ ARTICLE
Peptide Therapy Certification 2026
The SSRP Peptide Therapy Certification course gives clinicians, researchers, and other healthcare providers a working method for applying Cellular Medicine principles to patient care through clinical peptide therapy. Across 19 faculty-led lessons, Dr. William Seeds and SSRP faculty, including Siobhan...
19 Lessons
15 hrs 43 min
View Course